Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Pharmacy Licensing topic
No spam. Unsubscribe anytime.
Drug-control commission approves multiple new pharmacy licenses, relocations and remodels
Summary
The Consumer Protection Department's drug-control commission approved a slate of new pharmacy licenses, relocations and remodels, including Blue Oak Pharmacy and a Stamford relocation, and set USP 800 documentation conditions for one remodel. A commissioner with remote audio issues did not vote on one item.
The Consumer Protection Department's drug-control commission approved several new pharmacy licenses, relocations and remodels at its meeting, voting to accept applications for a mix of resident and nonresident pharmacies and to clear planned remodels pending technical compliance.
The approvals included the Blue Oak Pharmacy application and a relocation for Anchor Health Initiative Corporation from Suite 16 to Suite 10 at 30 Miano Lane in Stamford, along with remodel approvals for Main Street Pharmacy and others. The commission also accepted previously reviewed nonresident applications after applicants supplied supplemental documentation.
Why it matters: licensing, relocations and remodel approvals determine local access to medications, where controlled substance accountability and sterile compounding rules apply, and whether pharmacies meet state inspection and USP 800 standards.
The chair (role label) led questioning of applicants. During the Blue Oak review, commissioners asked whether physician ownership existed (applicant said no), whether sterile compounding would occur (applicant said no), and how modular point-of-sale units in hospital suites would be secured; the applicant said the units would be locked and under staff control at the end of each business day. After discussion a motion to approve the Blue Oak application was made and carried by voice vote; the chair noted one remote commissioner experiencing connection problems would recuse from that portion of the agenda and not vote.
Main Street Pharmacy's remodel at 2117 Boston Avenue in Bridgeport was approved subject to submission of USP 800 compliance documentation and updated plans reflecting a larger footprint. Commissioners explicitly conditioned that approval on receiving the USP 800 inspection/plan, and staff were instructed to file the larger-footprint plans with board administrator Gina Samples.
Commissioner Iguodate flagged several nonresident applicants that warranted closer review earlier in the meeting (including American Life Pharmacy and others with prior electronic actions or incomplete inspection records). For nonresident applications that later supplied the requested information, the commission approved those files without further delay.
What's next: staff are to confirm receipt of pending USP 800 documentation and updated blueprints for the Bridgeport remodel, and to record the approvals in the department's licensing system. The commission did not assign additional conditions beyond those stated for each approval at the meeting.
Quote: "They will be outside of pharmacist area, but in control of staff," the applicant said when asked how modular units would be secured.
The commission moved through the agenda and adjourned after accepting minutes and closing formal business.
